ロード中...
SRT2183 impairs ovarian cancer by facilitating autophagy
The 5-year survival rate of ovarian cancer patients is only 47%, and developing novel drugs for ovarian cancer is needed. Herein, we evaluated if and how SRT2183, a sirtuin-1 activator, impairs the ovarian cancer cells. OVCAR-3 and A2780 cells were treated with SRT2183. Cell viability was measured b...
保存先:
| 出版年: | Aging (Albany NY) |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7762476/ https://ncbi.nlm.nih.gov/pubmed/33223507 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/aging.104126 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|